Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells
- 1 March 2012
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 316 (1) , 11-22
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptorProceedings of the National Academy of Sciences, 2010
- Talin1 Promotes Tumor Invasion and Metastasis via Focal Adhesion Signaling and Anoikis ResistanceCancer Research, 2010
- Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor PathwaysPLOS ONE, 2009
- A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant GrowthCancer Research, 2009
- Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate CancerCancer Research, 2008
- Splicing of a Novel Androgen Receptor Exon Generates a Constitutively Active Androgen Receptor that Mediates Prostate Cancer Therapy ResistanceCancer Research, 2008
- Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptorProceedings of the National Academy of Sciences, 2007
- Antiandrogens in the Treatment of Prostate CancerEuropean Urology, 2007
- Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitroExperimental & Molecular Medicine, 2005